Related Experiment Video
Updated: Oct 7, 2025
06:10
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
491
Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering
Cuilin Zhang1,2, Qiuyu Zhuang1,2, Jingfeng Liu1,3
1The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
ACS Synthetic Biology
|January 10, 2022
Summary
Synthetic biology advances chimeric antigen receptor (CAR) T cell therapy for blood cancers. Bioengineering strategies are crucial for overcoming limitations in solid tumor treatment, enhancing efficacy and safety.
Area of Science:
- Synthetic biology
- Bioengineering
- Immunotherapy
Background:
- Chimeric antigen receptor (CAR) T cells show promise in treating hematological malignancies.
- Current CAR T cell therapies face challenges like toxicity, antigen escape, and poor solid tumor infiltration.
- Limitations hinder the widespread application of CAR T cell therapies.
Purpose of the Study:
- To summarize bioengineering strategies for improving CAR T cell therapy.
- To discuss future synthetic biology approaches for overcoming CAR T cell limitations.
- To enhance CAR T cell efficacy and minimize side effects in cancer treatment.
Main Methods:
- Review of current bioengineering strategies in synthetic biology for CAR T cell development.
- Analysis of methods to improve CAR T cell homing, infiltration, and survival in solid tumors.
- Discussion of innovative CAR designs to address therapeutic challenges.
Main Results:
- Synthetic biology offers novel engineering principles for CAR T cell design.
- Bioengineering strategies are being developed to address toxicity and efficacy issues.
- Improved CAR designs aim to enhance CAR T cell function in solid tumors.
Conclusions:
- Innovative CAR design is essential for advancing T cell therapy.
- Synthetic biology approaches hold significant potential for overcoming current limitations.
- Future research should focus on engineering CAR T cells for broader and safer clinical application.
